Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have chosen to have a focused ultrasound treatment (called HIFU) for prostate cancer that has come back after radiation therapy
- You are male and 18 years of age or older
- You are able to carry out some or all of your normal daily activities (your doctor can confirm this based on a standard scale from 0–3)
- Your prostate cancer was previously treated with radiation therapy, with or without hormone therapy
- You have had an MRI scan or a special type of PET scan (called a PSMA PET scan) that identified a specific area of concern in the prostate
- A biopsy taken within the last 6 months has confirmed that significant prostate cancer has returned in or near the area identified on your scan
- Any cancer found on the opposite side of the prostate is a low-grade, less aggressive type (confirm with trial site)
- Your PSMA PET scan, taken within 6 months of your biopsy, shows the cancer has not spread to other parts of the body
- You have no more than one active cancer at the time of joining (some exceptions may apply — confirm with trial site)
- You are willing to give written consent and follow all study procedures
Who may not be able to join:
- You have a latex allergy, no rectum, or have had significant rectal surgery that would make the ultrasound probe unsafe to use
- You have received hormone therapy within the 6 months before screening (this includes tablets or injections used to lower or block testosterone)
- You have had Inflammatory Bowel Disease that required active treatment in the last 3 years
- Imaging shows your cancer has grown significantly beyond the prostate (confirm with trial site)
- Significant prostate cancer is found on both sides of the prostate
- You still have radioactive seeds in your prostate from a previous brachytherapy treatment
- You have internal marker clips or seeds that would directly block the ultrasound treatment reaching the target area, as assessed by your surgeon
- You have large calcium deposits in the prostate area that your surgeon feels would interfere with the ultrasound treatment
- You have had an active urethral narrowing (stricture) in the last 6 months or have needed more treatment than simple self-catheterisation for it
- You have never had radiation therapy for prostate cancer
- No specific target area was identified on your MRI or PET scan
- Your scan shows the cancer has spread to lymph nodes in the pelvis, other parts of the body, or has grown into nearby structures
- You have another medical condition that your doctor believes would make this treatment unsafe or affect the study results
- You are currently in prison or being held in a facility against your will
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tarik Benidir, MD, University of Florida
Phone: 352-392-0510
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
In-field failure-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.